Semaglutide was designed to keep working for a week.
See what late-stage, or phase-3, studies found, why a shot lasts, and which questions may help at your next visit.
The medicine copies your body's after-meal message
Researchers at Novo Nordisk wanted the gut hormone GLP-1 to keep acting longer, and that's the work that led to semaglutide, which gives your pancreas the cue to release insulin after a meal. It slows digestion and helps your brain tell when you've had enough to eat. That natural hormone fades within minutes, while the medicine stays active across seven days.
A doctor may offer semaglutide for type 2 diabetes or long-term weight care. In some people, it may lower heart attack or stroke risk as well. Since 2025, doctors have also used it for a serious fatty liver disease. You'd have one weekly shot, while the pill is taken each day. Nausea is the most common problem, mainly after starting or raising the amount. I'd ask which stomach signs mean you need to call. The effects page explains more.
Semaglutide stays in your blood for about a week
Doctors call your after-meal hormone glucagon-like peptide-1, or GLP-1. It's one of your body's natural messages. Half-life means the time until only half the medicine is left in your blood. For semaglutide, that's one week, or 165 to 168 hours. Nearly all leaves about five weeks following the final amount [13][15]. Your natural GLP-1 lasts only two minutes.
The makers changed semaglutide so it wouldn't vanish so fast. About 94% matches human GLP-1 [15]. At protein piece 8, one change keeps a cutting chemical called DPP-4 from breaking up the drug. Once DPP-4 is blocked, the medicine lasts longer. Another part lets it cling to albumin, an abundant protein in your blood. Your kidneys can't remove it as quickly. A weekly shot is possible because of that slow exit. Semaglutide half life explains the timing.
Large studies found less weight, heart harm, and kidney harm
STEP 1, the large weight study, didn't include people with diabetes. It followed 1,961 adults with excess weight. With semaglutide 2.4 mg, their average change was -14.9% by week 68. A placebo, meaning an inactive shot, led to an average of -2.4%. The difference was about 12.4 percentage points [1]. Your own change won't be fixed by either average.
The SUSTAIN-6 heart study included 3,297 people with type 2 diabetes and heart risk. Death tied to the heart, a heart attack they survived, or a stroke they survived happened less often with the drug. A 95% range showed how much the estimate could vary [2]. Another study followed 17,604 adults who had heart disease without diabetes. Their combined risk was 20% lower, with a 95% range [3]. A kidney study followed 3,533 adults with damage from diabetes. Serious kidney harm fell 24%, also with a 95% range [6]. Semaglutide research will help you compare those groups with yourself.
Slow increases helped limit stomach trouble in studies
Researchers raised the amount slowly because semaglutide stays for a week. That pace may ease nausea plus other gut problems. Weight studies began at 0.25 mg weekly for weeks 1-4. Later steps used 0.5 mg, 1.0 mg, and 1.7 mg. The final study amount was 2.4 mg [1][15]. Type 2 diabetes studies often aimed for 0.5 to 1.0 mg weekly. Some tested as much as 2.0 mg [15].
The daily pill used different steps: 3 mg, then 7 mg, then 14 mg [11][23]. A protective ingredient helps a little medicine pass through the stomach wall. Those figures describe research and don't set your care. Your doctor will consider your health, other pills, budget, and stomach. Read oral semaglutide about the pill or dosage research context about study plans. Neither page can tell you what fits.
Your next question points to the right page
You'll want the half-life page when you're wondering how slowly the drug leaves. Semaglutide effects covers trouble people report and what studies found. It keeps personal stories separate from tested results. You'll also find who may need more care. Before a visit, note what bothers you, when it began, and what it costs in time or comfort. Semaglutide references lists the studies. You don't have to read them all first.